Explore 3 Stock Ideas & Industry Insights Download Free Report

Bionoid Pharma Inc

Company price
None USD 0.00(0%)
Last update at 2026-06-04T21:40:46.845097Z
Market Cap
1.37M

Momentum Score

…

AI Maverick Intel, Inc., an AI company, focuses on acquiring and enhancing businesses through its proprietary AI Maverick platform. Its technology streamlines the customer acquisition process by automating two way communication and data-driven engagement with its clients ideal audience segments across healthcare, biotech, and other sectors. The company was formerly known as Bionoid Pharma Inc. and changed its name to AI Maverick Intel, Inc. in April 2025. AI Maverick Intel, Inc. was incorporated in 2006 and is based in Beverly Hills, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.01
Low
0.15
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.09M
Revenue Per Share
2.63
Gross Profit TTM
0.05M
Debt / Equity
-1.84
ROE
-
Net Debt
0.15M
ROCE
-331.07%
Diluted EPS TTM
-0.16

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.28M 0.01M 0.00M -0.14M -0.46M
Net income -0.32M 0.01M 0.00M -0.14M -0.46M
Gross profit -0.28M 0.01M 0.02M 0.05M 0.01M
Ebit 0.28M -0.01M 0.00M -0.14M -0.03M
Ebitda 0.55M -0.00M 0.00M -0.13M -0.03M
Depreciation and amortization 0.28M 0.00M 0.00M 0.00M 0.00M
Operating income -0.28M 0.01M 0.00M -0.08M -0.03M
Other operating expenses 0.28M 0.04M 0.03M 0.18M 0.06M
Interest expense 0.00M 0.00M 0.00M 0.00M -
Income tax expense - -0.01M 0.00M -0.00M -
Total revenue - 0.04M 0.04M 0.10M 0.03M
Total operating expenses - 0.02M 0.02M 0.13M 0.05M
Cost of revenue 0.28M 0.03M 0.02M 0.06M 0.02M
Total other income expense net -0.00M -0.00M -0.00M -0.06M -0.42M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets - 0.07M 0.08M 0.08M 0.12M
Intangible assets - 0.02M 0.02M 0.02M -
Other current assets - 0.05M 0.06M -0.01M 0.12M
Total liab - 0.15M 0.16M 0.16M 0.16M
Total stockholder equity - -0.08M -0.08M -0.08M -0.04M
Other current liab - -0.00M - 0.00M -
Common stock - 0.01M 1.46M 1.46M 1.44M
Retained earnings - -19.18M -20.71M -20.72M -20.58M
Other assets - - - 0.00M -
Cash - 0.00M 0.00M 0.02M 0.00M
Total current liabilities - 0.15M 0.16M 0.16M 0.16M
Net debt - 0.15M 0.15M 0.13M 0.16M
Short term debt - 0.15M 0.15M 0.15M 0.16M
Short long term debt total - 0.15M 0.15M 0.15M 0.16M
Other stockholder equity - 19.09M -1.46M -1.46M -1.44M
Total current assets - 0.05M 0.06M 0.06M 0.12M
Net receivables - - - 0.04M -
Accounts payable - 0.00M 0.00M 0.01M -
Accumulated other comprehensive income - - 20.64M 20.64M 20.54M
Non currrent assets other - -0.04M - -0.00M -
Non current assets total - 0.02M 0.02M 0.02M -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total cashflows from investing activities - - 0.02M - -
Total cash from financing activities - -0.00M 0.02M 0.05M -0.11M
Net income -0.01M 0.00M -0.09M -0.46M 0.03M
Change in cash 0.00M -0.02M 0.02M 0.00M 0.00M
Begin period cash flow 0.00M 0.02M 0.00M 0.00M -0.00M
End period cash flow 0.00M 0.00M 0.02M 0.00M 0.00M
Total cash from operating activities 0.00M -0.02M -0.02M -0.05M 0.07M
Depreciation 0.00M 0.00M 0.00M 0.00M 0.00M
Change to inventory - - -0.04M - -
Change to account receivables - - 0.04M - -
Sale purchase of stock - - - - -0.17M
Other cashflows from financing activities - -0.00M 0.02M -0.00M -0.11M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.01M -0.03M -0.03M - -
Other non cash items 0.01M 0.01M 0.09M 0.41M 0.04M
Free cash flow 0.00M -0.02M -0.02M -0.05M 0.07M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
ABT
Abbott Laboratories
-
-%
109.40 25.97 17.24 3.57 3.20 16.75
MDT
Medtronic PLC
-0.41
0.41%
98.88 26.60 15.87 3.35 2.08 14.12
SYK
Stryker Corporation
3.74
1.22%
310.55 29.23 16.86 4.18 4.51 17.16
SEMHF
Siemens Healthineers AG
0.66
1.38%
48.35 39.57 21.32 3.01 3.29 16.92

Profile*

Bionoid Pharma Inc

AI Maverick Intel, Inc., an AI company, focuses on acquiring and enhancing businesses through its proprietary AI Maverick platform. Its technology streamlines the customer acquisition process by automating two way communication and data-driven engagement with its clients ideal audience segments across healthcare, biotech, and other sectors. The company was formerly known as Bionoid Pharma Inc. and changed its name to AI Maverick Intel, Inc. in April 2025. AI Maverick Intel, Inc. was incorporated in 2006 and is based in Beverly Hills, California.

433 North Camden, Beverly Hills, CA, United States, 90210

800 784 7641

5

Name Title Year Born
Ms. Patricia Colvin Director of Operations & Financial Controller NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…